Steve Schonfeld’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.97M | Buy |
+4,759
| New | +$3.24M | 0.01% | 869 |
|
|
2025
Q4 | – | Sell |
-2,634
| Closed | -$1.48M | – | 2505 |
|
|
2025
Q3 | $1.48M | Sell |
2,634
-5,210
| -66% | -$2.95M | 0.01% | 1190 |
|
|
2025
Q2 | $4.12M | Sell |
7,844
-36
| -0.5% | -$20.1K | 0.03% | 631 |
|
|
2025
Q1 | $5M | Sell |
7,880
-14,508
| -65% | -$9.98M | 0.03% | 523 |
|
|
2024
Q4 | $15.9M | Buy |
22,388
+18,496
| +475% | +$15.5M | 0.09% | 192 |
|
|
2024
Q3 | $4.09M | Buy |
3,892
+2,492
| +178% | +$2.77M | 0.03% | 613 |
|
|
2024
Q2 | $1.47M | Buy |
+1,400
| New | +$1.36M | 0.01% | 1040 |
|
|
2024
Q1 | – | Sell |
-1,500
| Closed | -$1.32M | – | 2339 |
|
|
2023
Q4 | $1.32M | Sell |
1,500
-2,535
| -63% | -$2.09M | 0.01% | 943 |
|
|
2023
Q3 | $3.32M | Buy |
4,035
+3,127
| +344% | +$2.46M | 0.03% | 667 |
|
|
2023
Q2 | $652K | Sell |
908
-2,720
| -75% | -$2.1M | 0.01% | 1119 |
|
|
2023
Q1 | $2.98M | Buy |
+3,628
| New | +$2.74M | 0.03% | 591 |
|
|
2022
Q4 | – | Sell |
-5,380
| Closed | -$3.71M | – | 2941 |
|
|
2022
Q3 | $3.71M | Sell |
5,380
-8,400
| -61% | -$5.29M | 0.03% | 632 |
|
|
2022
Q2 | $8.15M | Buy |
13,780
+12,519
| +993% | +$8.14M | 0.08% | 332 |
|
|
2022
Q1 | $881K | Buy |
+1,261
| New | +$798K | 0.01% | 1058 |
|
|
2021
Q4 | – | Sell |
-1,741
| Closed | -$1.05M | – | 2465 |
|
|
2021
Q3 | $1.05M | Sell |
1,741
-17,432
| -91% | -$10.8M | 0.01% | 931 |
|
|
2021
Q2 | $10.7M | Buy |
19,173
+9,638
| +101% | +$4.88M | 0.11% | 268 |
|
|
2021
Q1 | $4.51M | Buy |
9,535
+7,935
| +496% | +$3.86M | 0.05% | 453 |
|
|
2020
Q4 | $773K | Buy |
+1,600
| New | +$864K | 0.01% | 895 |
|
|
2020
Q2 | – | Sell |
-2,454
| Closed | -$1.2M | – | 1508 |
|
|
2020
Q1 | $1.2M | Buy |
+2,454
| New | +$1.01M | 0.08% | 313 |
|
|
2019
Q3 | – | Sell |
-6,300
| Closed | -$1.97M | – | 1203 |
|
|
2019
Q2 | $1.97M | Sell |
6,300
-6,200
| -50% | -$2.06M | 0.07% | 292 |
|
|
2019
Q1 | $5.13M | Sell |
12,500
-9,144
| -42% | -$3.77M | 0.18% | 153 |
|
|
2018
Q4 | $8.08M | Buy |
21,644
+19,144
| +766% | +$7.01M | 0.31% | 77 |
|
|
2018
Q3 | $1.01M | Sell |
2,500
-2,400
| -49% | -$913K | 0.04% | 428 |
|
|
2018
Q2 | $1.69M | Buy |
+4,900
| New | +$1.53M | 0.09% | 300 |
|
|
2017
Q3 | – | Sell |
-12,500
| Closed | -$6.14M | – | 750 |
|
|
2017
Q2 | $6.14M | Sell |
12,500
-11,500
| -48% | -$5.03M | 0.63% | 28 |
|
|
2017
Q1 | $9.3M | Buy |
24,000
+8,000
| +50% | +$2.97M | 0.93% | 11 |
|
|
2016
Q4 | $5.87M | Buy |
+16,000
| New | +$6.08M | 0.76% | 19 |
|
Other funds holding REGN
Steve Schonfeld's REGN Position: Q2 2026 in Review
Steve Schonfeld opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 4,759 shares worth $2.97M. The stake represents 0.01% of the portfolio and ranks #869 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in REGN as recently as Q3 2025.
Steve Schonfeld first reported a position in REGN in Q4 2016 and has held it in 27 quarters since. The position peaked at $15.9M in Q4 2024. 1,328 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Steve Schonfeld held 4,759 shares of Regeneron Pharmaceuticals worth $2.97M as of Q2 2026.
- Regeneron Pharmaceuticals was a new Steve Schonfeld position in Q2 2026.
- Regeneron Pharmaceuticals made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #869 holding.
- Steve Schonfeld first reported a position in Regeneron Pharmaceuticals in Q4 2016 and has held it in 27 quarters since.
- Steve Schonfeld's Regeneron Pharmaceuticals position peaked at $15.9M in Q4 2024.
- 1,328 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.